W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Transparency Council

Position of the Transparency Council – Keytruda (pembrolizumab)

more...

Position of the Transparency Council – Glypvilo (vildagliptin)

more...

Position of the Transparency Council – Saphnelo (anifrolumab)

more...

Opinion of the Transparency Council – amendments to the prenatal testing programme

more...

Opinion of the Transparency Council – health policy programme for the of the Municipality of Miękinia on vaccination against meningococcus type B

more...

Opinion of the Transparency Council – health policy programme of the Opolskie Voivodeship to support the diagnosis and treatment of infertility

more...

Opinion of the Transparency Council – lenalidomide

more...

Position of the Transparency Council – Vimetso (vildagliptin + metformin hydrochloride)

more...

Opinion of the Transparency Council – health policy programme of the City of Tychy in the scope of infertility treatment with IVF technique

more...

Opinion of the Transparency Council – health policy programme of the Municipality of Sztutowo in the field of health needs and health status

more...

Position of the Transparency Council – Xiaflex/Xiapex (collagenase Clostridium histolyticum)

more...

Position of the Transparency Councii – Findarts Duo (dutasteride + tamsulosin hydrochloride)

more...

Position of the Transparency Council – Kyprolis (carfilzomib)

more...

Opinion of the Transparency Council – abiraterone acetate

more...

Opinion of the Transparency Council – amendments to the drug programme B.56

more...

Opinion of the Transparency Council – trastuzumab

more...

Opinion of the Transparency Council – amendments to the drug programme B.47

more...

Opinion of the Transparency Council – stiripentol

more...

Opinion of the Transparency Council – amendments to the drug programme B.90

more...

Position of the Transparency Council – Apexxnar

more...

Position of the Transparency Councii – Lorviqua (lorlatinib)

more...

Opinion of the Transparency Council – venlafaxine

more...

Opinion of the Transparency Council – metformin

more...

Opinion of the Transparency Council – chloroquine

more...